Cai R. Ytsma

Cai R. Ytsma

Auto-generated profile, based on publicly available information

Cai R. Ytsma

Institute of Health Informatics, University College London, London, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in Nature Medicine
Verified
Journal Article
Open access
PDF file
JCJulia Carrasco-Zanini
Julia Carrasco-Zanini
MPMaik Pietzner
Maik Pietzner
JDJonathan Davitte
Jonathan Davitte
PSPraveen Surendran
Praveen Surendran
DCDamien C. Croteau-Chonka
Damien C. Croteau-Chonka
CLClaudia Langenberg
Claudia Langenberg
For many diseases there are delays in diagnosis due to a lack of objective biomarkers for disease onset. Here, in 41,931 individuals from the United Kingdom Biobank Pharma Proteomics Project, we integrated measurements of ~3,000 plasma proteins with clinical information to derive sparse prediction models for the 10-year incidence of 218 common and rare diseases (81–6,038 cases). We then compared prediction models developed using proteomic data with models developed using either basic clinical information alone or clinical information combined with data from 37 clinical assays. The predictive performance of sparse models including as few as 5 to 20 proteins was superior to the performance of models developed using basic clinical information for 67 pathologically diverse diseases (median delta C-index = 0.07; range = 0.02–0.31). Sparse protein models further outperformed models developed using basic information combined with clinical assay data for 52 diseases, including multiple myeloma, non-Hodgkin lymphoma, motor neuron disease, pulmonary fibrosis and dilated cardiomyopathy. For multiple myeloma, single-cell RNA sequencing from bone marrow in newly diagnosed patients showed that four of the five predictor proteins were expressed specifically in plasma cells, consistent with the strong predictive power of these proteins. External replication of sparse protein models in the EPIC-Norfolk study showed good generalizability for prediction of the six diseases tested. These findings show that sparse plasma protein signatures, including both disease-specific proteins and protein predictors shared across several diseases, offer clinically useful prediction of common and rare diseases.

8 October 2024 in Communications Medicine
Verified
Journal Article
Open access
PDF file
MGMaría Gordillo-Marañón
María Gordillo-Marañón
ASAmand Schmidt
Amand Schmidt
AWAlasdair Warwick
Alasdair Warwick
CTChristopher Tomlinson
Christopher Tomlinson
CYCai Ytsma
Cai Ytsma
CFChris Finan
Chris Finan
Background: Despite the growing interest in the use of human genomic data for drug target identification and validation, the extent to which the spectrum of human disease has been addressed by genome-wide association studies (GWAS), or by drug development, and the degree to which these efforts overlap remain unclear.Methods: In this study we harmonize and integrate different data sources to create a sample space of all the human drug targets and diseases and identify points of convergence or divergence of GWAS and drug development efforts.Results: We show that only 612 of 11,158 diseases listed in Human Disease Ontology have an approved drug treatment in at least one region of the world. Of the 1414 diseases that are the subject of preclinical or clinical phase drug development, only 666 have been investigated in GWAS. Conversely, of the 1914 human diseases that have been the subject of GWAS, 1121 have yet to be investigated in drug development.Conclusions: We produce target-disease indication lists to help the pharmaceutical industry to prioritize future drug development efforts based on genetic evidence, academia to prioritize future GWAS for diseases without effective treatments, and both sectors to harness genetic evidence to expand the indications for licensed drugs or to identify repurposing opportunities for clinical candidates that failed in their originally intended indication.

23 April 2023 in Geophysical Research Letters
Verified
Journal Article
Open access
KLK. H. Lepore
K. H. Lepore
MDM. D. Dyar
M. D. Dyar
CYC. R. Ytsma
C. R. Ytsma
Laser‐induced breakdown spectra (LIBS) were collected on a diverse suite of ∼2,600 geological standards using four laser energies (2.4–7.2 mJ) to assess how variations in irradiance from stand‐off distance affect prediction accuracy. Mismatches in laser energies and plasma temperatures between training and prediction datasets introduce substantial uncertainty in major element predictions. For example, using 2.4 mJ spectra to predict 7.2 mJ data results in errors of ±8.9, ±1.4, ±3.8, ±3.2, ±1.6, ±1.0, ±0.6, and ±1.0 wt% for SiO2, TiO2, Al2O3, Fe2O3, MgO, CaO, Na2O, and K2O, respectively. When plasma temperatures of unknowns are represented in a multiple‐plasma‐temperature training set, prediction accuracies improve for the same oxides: ±3.0, ±0.3, ±1.3, ±1.4, ±1.0, ±0.7, ±0.5, and ±0.5 wt%. These results suggest that accuracies reported for Mars LIBS predictions based on single‐distance, single laser‐power calibration data may be overly optimistic except where Mars plasmas serendipitously match those acquired in the laboratory.

28 September 2024 in Earth and Space Science
Verified
Journal Article
Open access
MDM. D. Dyar
M. D. Dyar
CYC. R. Ytsma
C. R. Ytsma
KLK. Lepore
K. Lepore
After its successful implementation on the surface of Mars, laser‐induced breakdown spectroscopy (LIBS) is likely to be employed on a diverse array of other solid bodies in our Solar System. Here we address the accuracy and quantification limits of LIBS under the vacuum conditions found on the Moon relative to what is known about its geochemistry. The interplay among accuracy as represented by root mean‐squared errors (RMSE), the median concentration, and quantification limits (LOQ) of LIBS analyses for each of 69 elements is evaluated. This comparison shows that several key elements in lunar geochemistry cannot be well‐studied with LIBS, including K2O, S, Rb, Br, and C. Conversely, highly accurate analyses of SiO2, CaO, and many minor and trace elements such as Mn, Yb, and Zn are possible under conditions found on the Moon. Use of LIBS must always be considered in the context of the geochemistry and geology of the target materials.

13 June 2024 in Earth and Space Science
Verified
Journal Article
Open access
CLC. J. Leight
C. J. Leight
CYC. Ytsma
C. Ytsma
MMM. C. McCanta
M. C. McCanta
MDM. D. Dyar
M. D. Dyar
TGT. D. Glotch
T. D. Glotch
The glass phase in volcanic rocks presents a challenge to obtaining compositional data from visible and short‐wave‐infrared (VSWIR) and mid‐infrared (MIR) spectral data of remote surfaces due to its amorphous structure and variable composition. Nonetheless, glass is a common phase in volcanic materials because it forms via the rapid quench of magma and can constitute up to the entirety of a volcanic deposit. Use of partial least squares regression (PLS) to predict glass contents creates models that are insensitive to viewing geometry and sample conditions such as grain size and spectrally inactive compositional variables, enhancing the ability to detect glasses with remote sensing. PLS models are used here to predict crystallinity and oxide composition of samples from VSWIR and MIR spectral data using training spectra from natural volcanic rocks and geologically relevant synthetic samples. Three spectral resolutions of VSWIR and MIR spectra (1, 10, and 100 nm/band, and 1.9, 19, and 190 cm−1/band, respectively) were tested to assess the effects of collection configuration on different spectrometers. PLS models trained on 1 nm and 1.9 cm−1 data sets have the lowest uncertainties of glass modal abundance for VSWIR and MIR, respectively. MIR models predicting sample wt. % SiO2 and FeO, and VSWIR models of wt. % FeO provide accurate estimates (e.g., RMSE‐P of 3.4 wt. % FeO) at all spectral resolutions. Results are based on training data sets skewed to mafic compositions, which affects model accuracies.

25 October 2023 in JACC: Advances
Verified
Journal Article
Open access
SCSheng-Chia Chung
Sheng-Chia Chung
MRMartin Rossor
Martin Rossor
ATAna Torralbo
Ana Torralbo
CYCai Ytsma
Cai Ytsma
NFNatalie K. Fitzpatrick
Natalie K. Fitzpatrick
RPRui Providencia
Rui Providencia